These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23883971)

  • 21. IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.
    Sucher R; Fischler K; Oberhuber R; Kronberger I; Margreiter C; Ollinger R; Schneeberger S; Fuchs D; Werner ER; Watschinger K; Zelger B; Tellides G; Pilat N; Pratschke J; Margreiter R; Wekerle T; Brandacher G
    J Immunol; 2012 Jan; 188(1):37-46. PubMed ID: 22131334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model].
    Zheng YX; Hou GH; Song J; Zhang C; Liang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):327-30. PubMed ID: 17428387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
    Xu H; Samy KP; Guasch A; Mead SI; Ghali A; Mehta A; Stempora L; Kirk AD
    Am J Transplant; 2016 Feb; 16(2):550-64. PubMed ID: 26436448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus.
    Singh K; Kozyr N; Stempora L; Kirk AD; Larsen CP; Blazar BR; Kean LS
    Am J Transplant; 2012 Jun; 12(6):1441-57. PubMed ID: 22300641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.
    Chavez H; Beaudreuil S; Abbed K; Taoufic Y; Kriaa F; Charpentier B; Durrbach A
    Transpl Immunol; 2007 Jun; 17(4):243-8. PubMed ID: 17493526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation.
    Davies JK; Barbon CM; Voskertchian A; Nadler LM; Guinan EC
    Cell Transplant; 2012; 21(9):2047-61. PubMed ID: 22507909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.
    Song L; Ma A; Dun H; Hu Y; Fujii Y; Kinugasa F; Oshima S; Higashi Y; Daloze P; Chen H
    Am J Transplant; 2017 Mar; 17(3):635-645. PubMed ID: 27598231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment.
    Furuzawa-Carballeda J; Lima G; Uribe-Uribe N; Avila-Casado C; Mancilla E; Morales-Buenrostro LE; Pérez-Garrido J; Pérez M; Cárdenas G; Llorente L; Alberú J
    Transplant Proc; 2010 Nov; 42(9):3489-96. PubMed ID: 21094802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of allogeneic cytotoxic T cell (CD8
    Kang N; Toyofuku WM; Yang X; Scott MD
    Acta Biomater; 2017 Jul; 57():146-155. PubMed ID: 28442414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation.
    Nafady-Hego H; Li Y; Ohe H; Elgendy H; Zhao X; Sakaguchi S; Bishop GA; Koshiba T
    Transpl Immunol; 2016 May; 36():1-8. PubMed ID: 27105585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation and tolerance.
    Knechtle SJ
    Transplant Proc; 2010 Nov; 42(9 Suppl):S13-5. PubMed ID: 21095443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive drugs affect induction of IFNy+ Treg in vitro.
    Daniel V; Trojan K; Opelz G
    Hum Immunol; 2016 Jan; 77(1):146-152. PubMed ID: 26585777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
    J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial.
    Libetta C; Esposito P; Gregorini M; Margiotta E; Martinelli C; Borettaz I; Canevari M; Rampino T; Ticozzelli E; Abelli M; Meloni F; Dal Canton A
    Transpl Immunol; 2015 Oct; 33(2):117-24. PubMed ID: 26220254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
    Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.
    Visner GA; Liu F; Bizargity P; Liu H; Liu K; Yang J; Wang L; Hancock WW
    Transplantation; 2009 Aug; 88(3):330-8. PubMed ID: 19667934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of cyclosporine on human regulatory T cells in vitro.
    Miroux C; Moralès O; Carpentier A; Dharancy S; Conti F; Boleslowski E; Podevin P; Auriault C; Pancré V; Delhem N
    Transplant Proc; 2009 Oct; 41(8):3371-4. PubMed ID: 19857752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.